APA (7th ed.) Citation

AR, K., PK, T., N, W., & M, S. (2024). Immortal Time Bias for Infliximab in Central Nervous System Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 78(2), 490. https://doi.org/10.1093/cid/ciad590

Chicago Style (17th ed.) Citation

AR, Khan, Tirlangi PK, Wig N, and Soneja M. "Immortal Time Bias for Infliximab in Central Nervous System Tuberculosis." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78, no. 2 (2024): 490. https://doi.org/10.1093/cid/ciad590.

MLA (9th ed.) Citation

AR, Khan, et al. "Immortal Time Bias for Infliximab in Central Nervous System Tuberculosis." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 2, 2024, p. 490, https://doi.org/10.1093/cid/ciad590.